IQVIA (IQV) news
Recent news
IQVIA selects Veeva clinical operations applications
AInvest Wire · 1d agoIQVIA Holdings Inc: Mizuho raises target price to $300 from $275
Mizuho Securities has revised its price target for IQVIA Holdings Inc. (IQV) to $300 from $275, reflecting a positive outlook on the company’s performance and strategic direction. The adjustment comes amid ongoing analyst evaluations of the healthcare services sector, where IQVIA remains key player…
AInvest Wire · 7d agoIQVIA Holdings Inc: Barclays raises target price to $300 from $275
Barclays has raised its price target for IQVIA Holdings Inc. (NYSE: IQV) to $300 from $275, reflecting growing confidence in the company’s near-term prospects and strategic positioning within the healthcare sector. This move aligns with a broader trend of analysts upgrading IQVIA’s outlook, with…
AInvest Wire · 7d agoIQVIA Holdings Inc.: UBS raises target price to $345 from $240
AInvest Wire · Sep 30, 2026IQVIA Holdings Inc.: RBC raises target price to $319 from $247
Royal Bank of Canada (RBC) has raised its target price for IQVIA Holdings Inc. (NYSE: IQV) to $319 from $247, reflecting a more optimistic outlook for the global healthcare data and analytics company. The adjustment comes amid strong recent financial performance, including IQVIA’s quarterly…
AInvest Wire · Sep 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.